Your browser doesn't support javascript.
loading
NPRL2 enhances autophagy and the resistance to Everolimus in castration-resistant prostate cancer.
Chen, Zhixiong; Jiang, Qilong; Zhu, Pingyu; Chen, Yanlin; Xie, Xuemei; Du, Zhongbo; Jiang, Li; Tang, Wei.
Affiliation
  • Chen Z; Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, P. R. China.
  • Jiang Q; Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, P. R. China.
  • Zhu P; Department of Urology, The Affiliated Hospital of North Sichuan Medical College,, Nanchong, P. R. China.
  • Chen Y; Department of Pathology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, P. R. China.
  • Xie X; Molecular and Pathological Diagnosis Center, Chongqing Medical University, Chongqing, P. R. China.
  • Du Z; Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, P. R. China.
  • Jiang L; Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, P. R. China.
  • Tang W; Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, P. R. China.
Prostate ; 79(1): 44-53, 2019 01.
Article in En | MEDLINE | ID: mdl-30178500

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autophagy / Drug Resistance, Neoplasm / Tumor Suppressor Proteins / Prostatic Neoplasms, Castration-Resistant / Everolimus / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Prostate Year: 2019 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autophagy / Drug Resistance, Neoplasm / Tumor Suppressor Proteins / Prostatic Neoplasms, Castration-Resistant / Everolimus / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Prostate Year: 2019 Type: Article